Skip to main content
. 2021 Feb 9;2:100022. doi: 10.1016/j.crmicr.2021.100022

Fig. 8.

Fig. 8

A comparative illustration representing the possible reasons for the higher susceptibility and fatality rate of the COVID-19 infected lung cancer patients rather than the COVID-19 infected healthy patients.